Lawrence B. Cohen’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-19,662
| Closed | -$1.36M | – | 63 |
|
|
2023
Q2 | $1.36M | Sell |
19,662
-8,223
| -29% | -$585K | 0.87% | 46 |
|
|
2023
Q1 | $2.07M | Buy |
27,885
+1,676
| +6% | +$141K | 1.39% | 36 |
|
|
2022
Q4 | $2.44M | Buy |
26,209
+513
| +2% | +$49.5K | 1.28% | 26 |
|
|
2022
Q3 | $2.45M | Sell |
25,696
-3,157
| -11% | -$312K | 1.89% | 16 |
|
|
2022
Q2 | $2.67M | Sell |
28,853
-680
| -2% | -$66.4K | 1.91% | 15 |
|
|
2022
Q1 | $2.99M | Sell |
29,533
-3,115
| -10% | -$327K | 1.77% | 19 |
|
|
2021
Q4 | $3.37M | Sell |
32,648
-4,604
| -12% | -$425K | 1.31% | 24 |
|
|
2021
Q3 | $3.16M | Sell |
37,252
-10,137
| -21% | -$849K | 1.67% | 24 |
|
|
2021
Q2 | $3.95M | Sell |
47,389
-2,380
| -5% | -$195K | 2.02% | 16 |
|
|
2021
Q1 | $3.74M | Sell |
49,769
-1,428
| -3% | -$104K | 2.03% | 18 |
|
|
2020
Q4 | $3.5M | Sell |
51,197
-1,353
| -3% | -$88K | 1.94% | 19 |
|
|
2020
Q3 | $3.07M | Sell |
52,550
-215
| -0.4% | -$13.4K | 1.86% | 20 |
|
|
2020
Q2 | $3.43M | Buy |
52,765
+455
| +0.9% | +$28.7K | 2.29% | 14 |
|
|
2020
Q1 | $3.1M | Buy |
52,310
+1,024
| +2% | +$68.4K | 2.43% | 12 |
|
|
2019
Q4 | $3.81M | Buy |
51,286
+850
| +2% | +$59.7K | 2.25% | 11 |
|
|
2019
Q3 | $3.18M | Sell |
50,436
-1,701
| -3% | -$101K | 2.08% | 18 |
|
|
2019
Q2 | $2.84M | Sell |
52,137
-820
| -2% | -$44.2K | 1.97% | 22 |
|
|
2019
Q1 | $2.86M | Buy |
52,957
+880
| +2% | +$54.3K | 2.01% | 23 |
|
|
2018
Q4 | $3.41M | Buy |
52,077
+96
| +0.2% | +$7.17K | 2.65% | 12 |
|
|
2018
Q3 | $4.09M | Sell |
51,981
-1,272
| -2% | -$90.9K | 2.78% | 10 |
|
|
2018
Q2 | $3.43M | Sell |
53,253
-6,859
| -11% | -$452K | 2.45% | 16 |
|
|
2018
Q1 | $3.74M | Sell |
60,112
-1,200
| -2% | -$86.1K | 2.51% | 16 |
|
|
2017
Q4 | $4.45M | Buy |
61,312
+20
| +0% | +$1.45K | 2.82% | 14 |
|
|
2017
Q3 | $4.98M | Sell |
61,292
-471
| -0.8% | -$37.3K | 3.25% | 10 |
|
|
2017
Q2 | $4.97M | Buy |
61,763
+2,250
| +4% | +$178K | 3.18% | 10 |
|
|
2017
Q1 | $4.67M | Buy |
59,513
+3,335
| +6% | +$266K | 2.88% | 11 |
|
|
2016
Q4 | $4.43M | Buy |
56,178
+3,235
| +6% | +$262K | 2.69% | 14 |
|
|
2016
Q3 | $4.71M | Buy |
52,943
+2,590
| +5% | +$244K | 2.8% | 13 |
|
|
2016
Q2 | $4.82M | Sell |
50,353
-200
| -0.4% | -$19.9K | 2.88% | 12 |
|
|
2016
Q1 | $5.24M | Buy |
50,553
+3,215
| +7% | +$313K | 3.43% | 8 |
|
|
2015
Q4 | $4.63M | Sell |
47,338
-307
| -0.6% | -$30.1K | 3.14% | 10 |
|
|
2015
Q3 | $4.6M | Buy |
47,645
+245
| +0.5% | +$25.8K | 3.2% | 10 |
|
|
2015
Q2 | $4.97M | Buy |
47,400
+160
| +0.3% | +$16.3K | 3.14% | 10 |
|
|
2015
Q1 | $4.88M | Buy |
47,240
+880
| +2% | +$89K | 2.97% | 13 |
|
|
2014
Q4 | $4.46M | Buy |
46,360
+23,705
| +105% | +$2.09M | 2.69% | 16 |
|
|
2014
Q3 | $1.8M | Buy |
22,655
+11,375
| +101% | +$897K | 1.19% | 28 |
|
|
2014
Q2 | $850K | Buy |
11,280
+8,200
| +266% | +$620K | 0.56% | 37 |
|
|
2014
Q1 | $231K | Buy |
+3,080
| New | +$218K | 0.16% | 63 |
|
|
2013
Q4 | – | Sell |
-3,650
| Closed | -$207K | – | 72 |
|
|
2013
Q3 | $207K | Buy |
+3,650
| New | +$217K | 0.16% | 69 |
|
Other funds holding CVS
Lawrence B. Cohen's CVS Position: Q3 2023 in Review
Lawrence B. Cohen sold out of CVS Health (CVS) in Q3 2023, closing a stake of 19,662 shares — an estimated $1.36M sold.
Lawrence B. Cohen first reported a position in CVS in Q3 2013 and held it in 39 quarters. The position peaked at $5.24M in Q1 2016. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.
- Lawrence B. Cohen reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
- Lawrence B. Cohen sold 19,662 CVS Health shares in Q3 2023, an estimated $1.36M.
- Lawrence B. Cohen first reported a position in CVS Health in Q3 2013 and held it in 39 quarters.
- Lawrence B. Cohen's CVS Health position peaked at $5.24M in Q1 2016.
- 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.
Based on Lawrence B. Cohen's 13F filing for Q3 2023, filed 23 Oct 2023.